Lee Ainslie's PFE Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 96,528 shares of Pfizer Inc. (PFE) worth $2.75 M, representing 0.02% of the portfolio. First purchased in 2015-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in PFE, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2016, adding 10.19 M shares. Largest reduction occurred in Q2 2017, reducing 9.78 M shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +96,528 | New Buy | 96,528 | $28.52 |
| Q4 2021 | -23,648 | Sold Out | 0 | $0.00 |
| Q3 2021 | +23,648 | New Buy | 23,648 | $43.01 |
| Q4 2020 | -17,444 | Sold Out | 0 | $0.00 |
| Q3 2020 | -117,369 | Reduce 87.06% | 17,444 | $36.69 |
| Q2 2020 | +125,705 | Add 1380.16% | 134,813 | $32.70 |
| Q1 2020 | +9,108 | New Buy | 9,108 | $32.61 |
| Q1 2019 | -159,570 | Sold Out | 0 | $0.00 |
| Q4 2018 | -45,380 | Reduce 22.14% | 159,570 | $43.65 |
| Q3 2018 | +204,950 | New Buy | 204,950 | $44.07 |
| Q4 2017 | -7.32 M | Sold Out | 0 | $0.00 |
| Q3 2017 | -2.73 M | Reduce 27.20% | 7.32 M | $35.70 |
| Q2 2017 | -9.78 M | Reduce 49.32% | 10.05 M | $33.59 |
| Q1 2017 | -3.02 M | Reduce 13.21% | 19.83 M | $34.21 |
| Q4 2016 | +1.47 M | Add 6.88% | 22.85 M | $32.48 |
| Q3 2016 | +2.95 M | Add 16.03% | 21.38 M | $33.87 |
| Q2 2016 | +10.19 M | Add 123.84% | 18.43 M | $35.21 |
| Q1 2016 | -3.07 M | Reduce 27.14% | 8.23 M | $29.64 |
| Q4 2015 | +4.36 M | Add 62.86% | 11.3 M | $32.28 |
| Q3 2015 | +6.94 M | New Buy | 6.94 M | $31.41 |
Lee Ainslie's Pfizer Investment FAQs
Lee Ainslie first purchased Pfizer Inc. (PFE) in Q3 2015, acquiring 6,937,928 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Pfizer Inc. (PFE) for 20 quarters since Q3 2015.
Lee Ainslie's largest addition to Pfizer Inc. (PFE) was in Q2 2016, adding 18,426,824 shares worth $648.81 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 96,528 shares of Pfizer Inc. (PFE), valued at approximately $2.75 M.
As of the Q3 2026 filing, Pfizer Inc. (PFE) represents approximately 0.02% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Pfizer Inc. (PFE) was 22,851,570 shares, as reported at the end of Q4 2016.